Clinical validation and application of targeted long-range polymerase chain reaction and long-read sequencing–based analysis for hemophilia: experience from a hemophilia treatment center in China
Journal of Thrombosis and Haemostasis · 2024
DOI: 10.1016/j.jtha.2024.08.013 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift Journal of Thrombosis and Haemostasis, 2024. Verfasst von Meizhen Shi und 12 weiteren Autor:innen. Beteiligte Einrichtung: Center for Medical Genetics and Genomics, The Second Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region, Ch…. Hauptthemen laut MEDLINE: Hemophilia A, Hemophilia B, Factor VIII, Polymerase Chain Reaction. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Guangxi Natural Science Foundation, Guangxi Medical University.
Abstract (Originalsprache)
BACKGROUND: Targeted long-read sequencing (LRS) is expected to comprehensively analyze diverse complex variants in hemophilia A (HA) and hemophilia B (HB) caused by the F8 and F9 genes, respectively. However, its clinical applicability still requires extensive validation. OBJECTIVES: To evaluate the clinical applicability of targeted LRS-based analysis compared with routine polymerase chain reaction (PCR)-based methods. METHODS: Gene variants of retrieved subjects were retrospectively and prospectively analyzed. Whole-genome sequencing was performed to further analyze undiagnosed cases. Breakpoints of novel genomic rearrangements were mapped and validated using long-distance PCR and long-range PCR combined with sequencing. RESULTS: In total, 122 subjects were retrieved. In retrospective analysis of the 90 HA cases, HA-LRS assay showed consistent results in 84 cases compared with routine methods and characterized 6 large deletions with their exact breakpoints confirmed by further validation in 6 cases (routine methods only presented failure in amplifying the involved exons). In prospective analysis of the 21 HA subjects, 20 variants of F8 were identified in 20 cases. For the remaining HA patient, no duplication/deletion or single-nucleotide variant (SNV)/insertion and deletion (InDel) was found, but a potential recombination involving exons 14 and 21 of F8 was observed by LRS. Whole-genome sequencing analysis and further verification defined a 30 478 base pairs (bp) tandem repeat involving exons 14 to 21 of F8. Among the 11 HB patients, HB-LRS analysis detected 11 SNVs/InDels in F9, consistent with routine methods. CONCLUSION: Targeted LRS-based analysis was efficient and comprehensive in identifying SNVs/InDels and genomic rearrangements of hemophilia genes, especially when we first expanded the panel to include F9. However, further investigation for complex gross rearrangement is still essential.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Medical Genetics and Genomics, The Second Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region, China; The Guangxi Health Commission Key Laboratory of Medical Genetics…
- The Second School of Medicine, Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region, China.
- Department of Hematology, The Second Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region, China.
- Berry Genomics Corporation, Beijing, China.
- Department of Neurology, The Second Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region, China. Electronic address: drljf98@163.com.
- Department of Hematology, The Second Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region, China. Electronic address: yinghuilai@sina.com.
Förderung
- National Natural Science Foundation of China
- Guangxi Natural Science Foundation
- Guangxi Medical University
Zitieren
APA
Shi, M., Ma, Y., Peng, X., Zhou, X., Cheng, Z., Xie, B., Wei, X., Gui, C., Mao, A., Lin, W., Luo, J., Lai, Y., & Gui, B. (2024). Clinical validation and application of targeted long-range polymerase chain reaction and long-read sequencing–based analysis for hemophilia: experience from a hemophilia treatment center in China. Journal of Thrombosis and Haemostasis. https://doi.org/10.1016/j.jtha.2024.08.013
Vancouver
Shi M, Ma Y, Peng X, Zhou X, Cheng Z, Xie B, et al. Clinical validation and application of targeted long-range polymerase chain reaction and long-read sequencing–based analysis for hemophilia: experience from a hemophilia treatment center in China. Journal of Thrombosis and Haemostasis. 2024. doi:10.1016/j.jtha.2024.08.013
BibTeX
@article{Shi2024,
author = {Shi, Meizhen and Ma, Yunting and Peng, Xianwei and Zhou, Xu and Cheng, Zifeng and Xie, Bobo and Wei, Xianda and Gui, Chunrong and Mao, Aiping and Lin, Wenting and Luo, Jiefeng and Lai, Yinghui and Gui, Baoheng},
title = {Clinical validation and application of targeted long-range polymerase chain reaction and long-read sequencing–based analysis for hemophilia: experience from a hemophilia treatment center in China},
journal = {Journal of Thrombosis and Haemostasis},
year = {2024},
doi = {10.1016/j.jtha.2024.08.013}
}
EUVIMED